Eli Lilly’s $3.25 billion acquisition of Kelonia Therapeutics caps startup’s tortuous ride - statnews.com
Kelonia Therapeutics, a small biotech company, long struggled to stay afloat. Now it's been acquired by Eli Lilly for $3.25 billion.... Read More
Source: STAT
Published: 2026-04-20T21:36:07Z
Author: Allison DeAngelis